RHYTHM PHARMACEUTICALS, INC. (RYTM)
Clinical trial NCT06436924 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-03-30 → 2026-03-19 3. primary completion date: 2025-12-30 → 2026-03-19 4. enrollment: 678 → 569 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical